ITGB2 and ovarian cancer: The results revealed that the expression of critical glycolytic enzymes (such as Glu, T4MCT4 and LdhB) in ITGB2 overexpressing ovarian cancer cells was obviously upregulated compared with that in the NC group, while the knockdown of PI3K and AKT reversed this change.